QI
HAE icon

QV Investors’s Haemonetics HAE Stock Holding History

QV Investors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Buy
30,720
+8,850
+40% +$576K 0.14% 62
2025
Q4 		$1.75M Hold
21,870
– – 0.14% 60
2025
Q3 		$1.07M Buy
21,870
+7,430
+51% +$460K 0.09% 61
2025
Q2 		$1.08M Buy
14,440
+3,200
+28% +$212K 0.11% 60
2025
Q1 		$714K Buy
+11,240
New +$764K 0.07% 64

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QV Investors's HAE Position: Q1 2026 in Review

QV Investors increased its Haemonetics (HAE) stake by 40% in Q1 2026, buying an estimated $576K and bringing the position to 30,720 shares worth $1.73M. The position accounts for 0.14% of the portfolio, ranked #62.

QV Investors first reported a position in HAE in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.75M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • QV Investors held 30,720 shares of Haemonetics worth $1.73M as of Q1 2026.
  • QV Investors bought 8,850 Haemonetics shares in Q1 2026, an estimated $576K.
  • Haemonetics made up 0.14% of QV Investors's portfolio in Q1 2026, its #62 holding.
  • QV Investors first reported a position in Haemonetics in Q1 2025 and has held it in 5 quarters since.
  • QV Investors's Haemonetics position peaked at $1.75M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on QV Investors's 13F filing for Q1 2026, filed 23 Apr 2026.